 | • レポートコード：B-GIR08C5738 • 出版社/出版日：GlobalInfoResearch / 2019年8月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、122ページ • 納品方法：Eメール • 産業分類：Medical Devices & Consumables |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートは、核治療薬の世界市場について調べ、まとめました。種類別セグメントは、ラジウム-223、ルテチウム-177、ヨウ素-131、その他等、用途別セグメントは、甲状腺、骨転移、リンパ腫、その他等に区分しました。核治療薬の世界市場概観、企業動向、企業別核治療薬シェア、市場規模推移、市場規模予測（2019年-2024年）、主要地域分析（北米、ヨーロッパ、アジア等）、主要国分析（日本、中国、アメリカ等）データなどの情報が含まれています。 ・核治療薬の市場概観 ・核治療薬の企業概要（事業概要、製品種類、販売量、価格、売上、市場シェア等） ・核治療薬の企業別販売動向、市場シェア、市場集中度、競争動向 ・核治療薬の世界市場規模 ・核治療薬の北米市場分析（アメリカ、カナダ、メキシコ等） ・核治療薬のアメリカ市場規模推移 ・核治療薬のカナダ市場規模推移 ・核治療薬のメキシコ市場規模推移 ・核治療薬のヨーロッパ市場分析（ドイツ、イギリス、ロシア、フランス、イタリア等） ・核治療薬のドイツ市場規模推移 ・核治療薬のイギリス市場規模推移 ・核治療薬のロシア市場規模推移 ・核治療薬のアジア太平洋市場分析（日本、中国、韓国、インド、東南アジア等） ・核治療薬の日本市場規模推移 ・核治療薬の中国市場規模推移 ・核治療薬の韓国市場規模推移 ・核治療薬のインド市場規模推移 ・核治療薬の東南アジア市場規模推移 ・核治療薬の南米市場分析（ブラジル、アルゼンチン等） ・核治療薬の中東・アフリカ市場分析（サウジアラビア、UAE、南アフリカ等） ・核治療薬の種類別分析/販売量、売上、市場シェア（ラジウム-223、ルテチウム-177、ヨウ素-131、その他） ・核治療薬の用途別分析/市場規模（甲状腺、骨転移、リンパ腫、その他） ・核治療薬の市場予測2019年-2024年（地域別予測、種類別予測、用途別予測） ・核治療薬の販売チャネル・代理店・貿易業者・ディーラー分析 |
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
Therapeutic nuclear medicines are a pharmaceutical formulation that consists of radioactive substances (radioisotopes). Therapeutic nuclear medicines are intending for the treatment of cancer, metastatic bone pain and other diseases. The radioactive material of therapeutic nuclear medicines is capable of killing the cancerous tissue, reducing the size of a tumor and reducing pain.
Scope of the Report:
Radioactive material, called radiopharmaceuticals, can be used to treat certain conditions. This is called nuclear medicine therapy.
North Americas is the largest consumption place, with a revenue market share nearly 44.8% in 2018. Following North Americas, Europe is the second largest consumption place with the revenue market share of 29% in 2018.
The worldwide market for Therapeutic Nuclear Medicines is expected to grow at a CAGR of roughly 17.2% over the next five years, will reach 1947.5 million US$ in 2024, from 879.8 million US$ in 2019, according to a new GIR (Global Info Research) study.
This report focuses on the Therapeutic Nuclear Medicines in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bayer
Novartis AG
China Isotope & Radiation
Dongcheng
Q BioMed
Curium Pharmaceuticals
Jubilant DraxImage
Lantheus
Spectrum Pharmaceuticals
Progenics Pharmaceuticals
International Isotopes
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Radium-223
Lutetium-177
Iodine-131
Other
Market Segment by Applications, can be divided into
Thyroid
Bone Metastasis
Lymphoma
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Therapeutic Nuclear Medicines product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Therapeutic Nuclear Medicines, with price, sales, revenue and global market share of Therapeutic Nuclear Medicines in 2017 and 2018.
Chapter 3, the Therapeutic Nuclear Medicines competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Therapeutic Nuclear Medicines breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Therapeutic Nuclear Medicines market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Therapeutic Nuclear Medicines sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Therapeutic Nuclear Medicines Introduction
1.2 Market Analysis by Type
1.2.1 Radium-223
1.2.2 Lutetium-177
1.2.3 Iodine-131
1.2.4 Other
1.3 Market Analysis by Applications
1.3.1 Thyroid
1.3.2 Bone Metastasis
1.3.3 Lymphoma
1.3.4 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Business Overview
2.1.2 Therapeutic Nuclear Medicines Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Novartis AG
2.2.1 Business Overview
2.2.2 Therapeutic Nuclear Medicines Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 China Isotope & Radiation
2.3.1 Business Overview
2.3.2 Therapeutic Nuclear Medicines Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Dongcheng
2.4.1 Business Overview
2.4.2 Therapeutic Nuclear Medicines Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Q BioMed
2.5.1 Business Overview
2.5.2 Therapeutic Nuclear Medicines Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Curium Pharmaceuticals
2.6.1 Business Overview
2.6.2 Therapeutic Nuclear Medicines Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Jubilant DraxImage
2.7.1 Business Overview
2.7.2 Therapeutic Nuclear Medicines Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Lantheus
2.8.1 Business Overview
2.8.2 Therapeutic Nuclear Medicines Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Spectrum Pharmaceuticals
2.9.1 Business Overview
2.9.2 Therapeutic Nuclear Medicines Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Progenics Pharmaceuticals
2.10.1 Business Overview
2.10.2 Therapeutic Nuclear Medicines Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 International Isotopes
2.11.1 Business Overview
2.11.2 Therapeutic Nuclear Medicines Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Therapeutic Nuclear Medicines Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.3.2 Top 6 Therapeutic Nuclear Medicines Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Therapeutic Nuclear Medicines Market Analysis by Regions
4.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Regions
4.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Regions (2014-2019)
4.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Regions (2014-2019)
4.2 North America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.3 Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.5 South America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5 North America Therapeutic Nuclear Medicines by Country
5.1 North America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
5.1.1 North America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
5.1.2 North America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
5.2 United States Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.3 Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
5.4 Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6 Europe Therapeutic Nuclear Medicines by Country
6.1 Europe Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
6.1.1 Europe Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
6.1.2 Europe Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
6.2 Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.3 UK Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.4 France Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.5 Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
6.6 Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7 Asia-Pacific Therapeutic Nuclear Medicines by Country
7.1 Asia-Pacific Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
7.2 China Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.3 Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.4 Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.5 India Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8 South America Therapeutic Nuclear Medicines by Country
8.1 South America Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
8.1.1 South America Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
8.1.2 South America Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
8.2 Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.3 Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
8.4 Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9 Middle East and Africa Therapeutic Nuclear Medicines by Countries
9.1 Middle East and Africa Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Therapeutic Nuclear Medicines Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Therapeutic Nuclear Medicines Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.3 Turkey Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.4 Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.5 Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
9.6 South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
10 Global Therapeutic Nuclear Medicines Market Segment by Type
10.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Therapeutic Nuclear Medicines Sales and Market Share by Type (2014-2019)
10.1.2 Global Therapeutic Nuclear Medicines Revenue and Market Share by Type (2014-2019)
10.2 Radium-223 Sales Growth and Price
10.2.1 Global Radium-223 Sales Growth (2014-2019)
10.2.2 Global Radium-223 Price (2014-2019)
10.3 Lutetium-177 Sales Growth and Price
10.3.1 Global Lutetium-177 Sales Growth (2014-2019)
10.3.2 Global Lutetium-177 Price (2014-2019)
10.4 Iodine-131 Sales Growth and Price
10.4.1 Global Iodine-131 Sales Growth (2014-2019)
10.4.2 Global Iodine-131 Price (2014-2019)
10.5 Other Sales Growth and Price
10.5.1 Global Other Sales Growth (2014-2019)
10.5.2 Global Other Price (2014-2019)
11 Global Therapeutic Nuclear Medicines Market Segment by Application
11.1 Global Therapeutic Nuclear Medicines Sales Market Share by Application (2014-2019)
11.2 Thyroid Sales Growth (2014-2019)
11.3 Bone Metastasis Sales Growth (2014-2019)
11.4 Lymphoma Sales Growth (2014-2019)
11.5 Other Sales Growth (2014-2019)
12 Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.1 Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2019-2024)
12.2 Therapeutic Nuclear Medicines Market Forecast by Regions (2019-2024)
12.2.1 North America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.2 Europe Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.3 Asia-Pacific Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.4 South America Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.2.5 Middle East and Africa Therapeutic Nuclear Medicines Market Forecast (2019-2024)
12.3 Therapeutic Nuclear Medicines Market Forecast by Type (2019-2024)
12.3.1 Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2024)
12.3.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2019-2024)
12.4 Therapeutic Nuclear Medicines Market Forecast by Application (2019-2024)
12.4.1 Global Therapeutic Nuclear Medicines Sales Forecast by Application (2019-2024)
12.4.2 Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
Figure Therapeutic Nuclear Medicines Picture
Table Product Specifications of Therapeutic Nuclear Medicines
Figure Global Sales Market Share of Therapeutic Nuclear Medicines by Types in 2018
Table Therapeutic Nuclear Medicines Types for Major Manufacturers
Figure Radium-223 Picture
Figure Lutetium-177 Picture
Figure Iodine-131 Picture
Figure Other Picture
Figure Therapeutic Nuclear Medicines Sales Market Share by Applications in 2018
Figure Thyroid Picture
Figure Bone Metastasis Picture
Figure Lymphoma Picture
Figure Other Picture
Figure United States Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Canada Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Mexico Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Germany Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure France Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure UK Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Russia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Italy Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure China Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Japan Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Korea Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure India Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Southeast Asia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Brazil Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Egypt Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Saudi Arabia Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure South Africa Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Figure Nigeria Therapeutic Nuclear Medicines Revenue (Value) and Growth Rate (2014-2024)
Table Bayer Basic Information, Manufacturing Base and Competitors
Table Bayer Therapeutic Nuclear Medicines Type and Applications
Table Bayer Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Novartis AG Basic Information, Manufacturing Base and Competitors
Table Novartis AG Therapeutic Nuclear Medicines Type and Applications
Table Novartis AG Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table China Isotope & Radiation Basic Information, Manufacturing Base and Competitors
Table China Isotope & Radiation Therapeutic Nuclear Medicines Type and Applications
Table China Isotope & Radiation Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Dongcheng Basic Information, Manufacturing Base and Competitors
Table Dongcheng Therapeutic Nuclear Medicines Type and Applications
Table Dongcheng Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Q BioMed Basic Information, Manufacturing Base and Competitors
Table Q BioMed Therapeutic Nuclear Medicines Type and Applications
Table Q BioMed Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Curium Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Type and Applications
Table Curium Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Jubilant DraxImage Basic Information, Manufacturing Base and Competitors
Table Jubilant DraxImage Therapeutic Nuclear Medicines Type and Applications
Table Jubilant DraxImage Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Lantheus Basic Information, Manufacturing Base and Competitors
Table Lantheus Therapeutic Nuclear Medicines Type and Applications
Table Lantheus Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Spectrum Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Type and Applications
Table Spectrum Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Progenics Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Type and Applications
Table Progenics Pharmaceuticals Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table International Isotopes Basic Information, Manufacturing Base and Competitors
Table International Isotopes Therapeutic Nuclear Medicines Type and Applications
Table International Isotopes Therapeutic Nuclear Medicines Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
Table Global Therapeutic Nuclear Medicines Sales by Manufacturer (2017-2018)
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer in 2017
Figure Global Therapeutic Nuclear Medicines Sales Market Share by Manufacturer in 2018
Table Global Therapeutic Nuclear Medicines Revenue by Manufacturer (2017-2018)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturer in 2017
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Manufacturer in 2018
Figure Top 3 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2018
Figure Top 6 Therapeutic Nuclear Medicines Manufacturer (Revenue) Market Share in 2018
Figure Global Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Global Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales by Regions (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales Market Share by Regions (2014-2019)
Table Global Therapeutic Nuclear Medicines Revenue by Regions (2014-2019)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions (2014-2019)
Figure Global Therapeutic Nuclear Medicines Revenue Market Share by Regions in 2018
Figure North America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure South America Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure North America Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table North America Therapeutic Nuclear Medicines Sales by Countries (2014-2019)
Table North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure North America Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Table North America Therapeutic Nuclear Medicines Revenue by Countries (2014-2019)
Table North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure North America Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure United States Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Canada Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Mexico Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table Europe Therapeutic Nuclear Medicines Sales by Countries (2014-2019)
Table Europe Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Table Europe Therapeutic Nuclear Medicines Revenue by Countries (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure Europe Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure Germany Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure UK Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure France Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Russia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Italy Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales by Countries (2014-2019)
Table Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure Asia-Pacific Therapeutic Nuclear Medicines Sales Market Share by Countries 2018
Table Asia-Pacific Therapeutic Nuclear Medicines Revenue by Countries (2014-2019)
Figure Asia-Pacific Therapeutic Nuclear Medicines Revenue Market Share by Countries 2018
Figure China Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Japan Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Korea Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure India Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Southeast Asia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure South America Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table South America Therapeutic Nuclear Medicines Sales by Countries (2014-2019)
Table South America Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure South America Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Table South America Therapeutic Nuclear Medicines Revenue by Countries (2014-2019)
Table South America Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure South America Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure Brazil Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Argentina Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Colombia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue and Growth Rate (2014-2019)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales by Countries (2014-2019)
Table Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Countries (2014-2019)
Figure Middle East and Africa Therapeutic Nuclear Medicines Sales Market Share by Countries in 2018
Table Middle East and Africa Therapeutic Nuclear Medicines Revenue by Countries (2014-2019)
Table Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries (2014-2019)
Figure Middle East and Africa Therapeutic Nuclear Medicines Revenue Market Share by Countries in 2018
Figure Saudi Arabia Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure UAE Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Egypt Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure Nigeria Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Figure South Africa Therapeutic Nuclear Medicines Sales and Growth Rate (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales Share by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Revenue by Type (2014-2019)
Table Global Therapeutic Nuclear Medicines Revenue Share by Type (2014-2019)
Figure Global Radium-223 Sales Growth (2014-2019)
Figure Global Radium-223 Price (2014-2019)
Figure Global Lutetium-177 Sales Growth (2014-2019)
Figure Global Lutetium-177 Price (2014-2019)
Figure Global Iodine-131 Sales Growth (2014-2019)
Figure Global Iodine-131 Price (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Other Price (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales by Application (2014-2019)
Table Global Therapeutic Nuclear Medicines Sales Share by Application (2014-2019)
Figure Global Bone Metastasis Sales Growth (2014-2019)
Figure Global Lymphoma Sales Growth (2014-2019)
Figure Global Other Sales Growth (2014-2019)
Figure Global Therapeutic Nuclear Medicines Sales, Revenue and Growth Rate (2019-2024)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Regions (2019-2024)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Regions (2019-2024)
Figure North America Sales Therapeutic Nuclear Medicines Market Forecast (2019-2024)
Figure Europe Sales Therapeutic Nuclear Medicines Market Forecast (2019-2024)
Figure Asia-Pacific Sales Therapeutic Nuclear Medicines Market Forecast (2019-2024)
Figure South America Sales Therapeutic Nuclear Medicines Market Forecast (2019-2024)
Figure Middle East and Africa Sales Therapeutic Nuclear Medicines Market Forecast (2019-2024)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Type (2019-2024)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Type (2019-2024)
Table Global Therapeutic Nuclear Medicines Sales Forecast by Application (2019-2024)
Table Global Therapeutic Nuclear Medicines Market Share Forecast by Application (2019-2024)
Table Distributors/Traders/ Dealers List
世界の治療用核医薬品市場2019 The global Therapeutic Nuclear Medicines market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report studies the global Therapeutic Nuclear Medicines market status and forecast, categorizes the global Therapeutic Nuclear …- 世界の濾胞性リンパ腫市場：市場規模・現状・予測 Follicular lymphoma is a type of blood cancer. It is the most common of the indolent (slow-growing) non-Hodgkin's lymphomas, and the second-most-common form of non-Hodgkin's lymphomas overall. It is defined as a lymphoma of follicle center B-cells (centrocytes and centroblasts), which has at least a…
- 濾胞性リンパ腫市場：世界及び中国市場分析・予測（～2024年） Follicular Lymphoma Therapeutic Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Follicular Lymphoma Therapeutic industry with a focus on the Chinese market. The report provides key statistics on the market status of the Follic…
- 甲状腺機能検査の世界市場予測 2024年：企業別、地域別、種類・用途別（～2024） Thyroid Function Tests (TFT) include various blood tests which are conducted to identify the functions of thyroid gland. Scope of the Report: The global Thyroid Function Tests market is valued at xx million USD in 2018 and is expected to reach xx million USD by the end of 2024, growing at a CAGR of …
- 甲状腺ホルモン障害薬の世界市場予測 2024年：メーカー別、地域別、種類・用途別 Scope of the Report: The worldwide market for Thyroid Hormone Disorder Drug is expected to grow at a CAGR of roughly over the next five years, will reach million US$ in 2024, from million US$ in 2019, according to a new GIR (Global Info Research) study. This report focuses on the Thyroid Hormone Dis…